
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 6, pp. 100079-100079
Open Access | Times Cited: 17
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 6, pp. 100079-100079
Open Access | Times Cited: 17
Showing 17 citing articles:
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
Liyan Yang, Zhonglei Wang
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115503-115503
Open Access | Times Cited: 64
Liyan Yang, Zhonglei Wang
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115503-115503
Open Access | Times Cited: 64
PDCD4 restricts PRRSV replication in an eIF4A-dependent manner and is antagonized by the viral nonstructural protein 9
Ruiping Wei, Xiaoxiao Zhang, Xiaoying Wang, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Closed Access | Times Cited: 4
Ruiping Wei, Xiaoxiao Zhang, Xiaoying Wang, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Closed Access | Times Cited: 4
Synthesis, biological evaluation and molecular docking studies of flavonol-3-O-β-D-glycoside as a potential inhibitor of SARS-CoV-2 main protease (3CLpro) in drug development for COVID-19
Gonca Çelik, Şengül Alpay Karaoğlu, Şeyma Suyabatmaz, et al.
International Journal of Biological Macromolecules (2025), pp. 139621-139621
Closed Access
Gonca Çelik, Şengül Alpay Karaoğlu, Şeyma Suyabatmaz, et al.
International Journal of Biological Macromolecules (2025), pp. 139621-139621
Closed Access
Predicting the Anti-SARS-CoV-2 Potential of Isoquinoline Alkaloids from Brazilian Siparunaceae Species Using Chemometric Tools
Brendo Araújo Gomes, Diégina Araújo Fernandes, Simony Carvalho Mendonça, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 633-633
Open Access
Brendo Araújo Gomes, Diégina Araújo Fernandes, Simony Carvalho Mendonça, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 633-633
Open Access
Selective Control by Pistacia vera L. and Its Carotenoid Zeaxanthin on SARS-CoV-2 Virus
Rosamaria Pennisi, Davide Gentile, Paola Trischitta, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1667-1667
Open Access
Rosamaria Pennisi, Davide Gentile, Paola Trischitta, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1667-1667
Open Access
Disrupting protease and deubiquitinase activities of SARS-CoV-2 papain-like protease by natural and synthetic products discovered through multiple computational and biochemical approaches
Muhammad Waqas, Saeed Ullah, Atta Ullah, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134476-134476
Closed Access | Times Cited: 3
Muhammad Waqas, Saeed Ullah, Atta Ullah, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134476-134476
Closed Access | Times Cited: 3
A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products
Ayesha Rafiq, Tooba Jabeen, Sana Aslam, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4860-4860
Open Access | Times Cited: 8
Ayesha Rafiq, Tooba Jabeen, Sana Aslam, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4860-4860
Open Access | Times Cited: 8
Strictinin, a Major Ingredient in Yunnan Kucha Tea Possessing Inhibitory Activity on the Infection of Mouse Hepatitis Virus to Mouse L Cells
Erh-Chuang Tu, Wei‐Li Hsu, Jason T. C. Tzen
Molecules (2023) Vol. 28, Iss. 3, pp. 1080-1080
Open Access | Times Cited: 7
Erh-Chuang Tu, Wei‐Li Hsu, Jason T. C. Tzen
Molecules (2023) Vol. 28, Iss. 3, pp. 1080-1080
Open Access | Times Cited: 7
Synthesis and modification of noscapine derivatives as promising future anticancer agents
F Nemati, Amir Ata Bahmani Asl, Peyman Salehi
Bioorganic Chemistry (2024) Vol. 153, pp. 107831-107831
Closed Access | Times Cited: 2
F Nemati, Amir Ata Bahmani Asl, Peyman Salehi
Bioorganic Chemistry (2024) Vol. 153, pp. 107831-107831
Closed Access | Times Cited: 2
Emerging insights into the structure-activity relationship of water-soluble polysaccharides in antiviral therapy
Akanksha Sharma, Ayesha Shahid, Riya Banerjee, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 10, pp. 100122-100122
Open Access | Times Cited: 6
Akanksha Sharma, Ayesha Shahid, Riya Banerjee, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 10, pp. 100122-100122
Open Access | Times Cited: 6
Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2
Renhui Dai, Hongwei Gao, Ruiling Su
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Renhui Dai, Hongwei Gao, Ruiling Su
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Brazilian Medicinal Plants and Their Metabolites as Potential Antivirals Against SARS-CoV-2: a Systematic Review of Experimental Findings
Diégina Araújo Fernandes, Brendo Araújo Gomes, Alicia Fontoura da Silva, et al.
Revista Brasileira de Farmacognosia (2024) Vol. 34, Iss. 5, pp. 883-898
Closed Access | Times Cited: 1
Diégina Araújo Fernandes, Brendo Araújo Gomes, Alicia Fontoura da Silva, et al.
Revista Brasileira de Farmacognosia (2024) Vol. 34, Iss. 5, pp. 883-898
Closed Access | Times Cited: 1
Photocatalytic reactions for the synthesis and derivatization of pharmaceutically significant heterocycles
Suman Majee, Km. Anjali, Devalina Ray
Elsevier eBooks (2024), pp. 183-222
Closed Access | Times Cited: 1
Suman Majee, Km. Anjali, Devalina Ray
Elsevier eBooks (2024), pp. 183-222
Closed Access | Times Cited: 1
Prospecting native and analogous peptides with anti-SARS-CoV-2 potential derived from the trypsin inhibitor purified from tamarind seeds
Anna Beatriz Santana Luz, Amanda Fernandes de Medeiros, Lucas Lima Bezerra, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 8, pp. 104886-104886
Open Access | Times Cited: 3
Anna Beatriz Santana Luz, Amanda Fernandes de Medeiros, Lucas Lima Bezerra, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 8, pp. 104886-104886
Open Access | Times Cited: 3
Structure-Based Virtual Identification of Natural Inhibitors of SARS-CoV-2 and its Delta and Omicron Variant Proteins
Abdullah R. Alanzi, Mohammad K. Parvez, Mohammed S. Al‐Dosari
Future Virology (2023) Vol. 18, Iss. 7, pp. 421-438
Open Access | Times Cited: 3
Abdullah R. Alanzi, Mohammad K. Parvez, Mohammed S. Al‐Dosari
Future Virology (2023) Vol. 18, Iss. 7, pp. 421-438
Open Access | Times Cited: 3
Natural phytoconstituents and herbal supplements: A potential therapeutic strategies against COVID infection
Ganesh Jayram Lamkhade, Pratik Dilip Deshmukh, Suvir Ramesh Darekar, et al.
World Journal of Biology Pharmacy and Health Sciences (2023) Vol. 13, Iss. 1, pp. 028-038
Open Access
Ganesh Jayram Lamkhade, Pratik Dilip Deshmukh, Suvir Ramesh Darekar, et al.
World Journal of Biology Pharmacy and Health Sciences (2023) Vol. 13, Iss. 1, pp. 028-038
Open Access
In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes
Abdullah R. Alanzi, Mohammad K. Parvez, Mohammed S. Al‐Dosari
Future Virology (2023) Vol. 18, Iss. 14, pp. 933-946
Open Access
Abdullah R. Alanzi, Mohammad K. Parvez, Mohammed S. Al‐Dosari
Future Virology (2023) Vol. 18, Iss. 14, pp. 933-946
Open Access